Replies to post #234905 on Biotech Values

[jbog]

IOVA -18%/AH on “provides update” PR:

I would have thought this would have been worked out prior to announcing a 4th Quarter submittal.

It's a area that we see everyday with drug submittals so I see the problem. I still believe in the product and the results are stellar.

My biggest question is the sales of such a treatment.